Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Komatsu in connection with the acquisition of Bracke Forest AB
Mandate

Vinge advises Komatsu in connection with the acquisition of Bracke Forest AB

July 01, 2022 Employment and Benefits Corporate Crime & Compliance Intellectual Property M&A Real Estate and Construction Banking and Finance

Vinge advises Komatsu Ltd. and its subsidiary Komatsu Forest AB in connection with the acquisition of Bracke Forest AB, a company that develops and manufactures soil preparation equipment and products for mechanized forest planting.

Vinge’s team consisted primarily of Jonas Johansson, Carl Fredrik Wachtmeister and Philip Moré (M&A), Johan Cederblad (Environment), Ulf Pyk (Real Estate and Banking & Finance), Isabell Nielsen, Lisa Hörnqvist and Karolina Fuhrman (Commercial Agreements, IT and GDPR), Michael Montner and Ian Jonson (IP), Ebba Svenburg (Employment), Tove Tullberg (Compliance) and Emy Rydén (Project Assistant).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026